Nausea is the single most common reason patients hesitate to start — or consider stopping — Semaglutide. In FDA clinical trials, nausea affected up to 44% of patients on the 2.4 mg maintenance dose, making it the most frequently reported side effect of the medication. The good news is that nausea on Semaglutide is largely…
Weight Loss Articles
